University of Toronto-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors

    Molecular Cancer, Vol. 22, Núm. 1

  2. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations

    The Lancet Oncology, Vol. 24, Núm. 4, pp. e172-e185

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer: Results from the multicohort phase II FINESSE study

    Clinical Cancer Research, Vol. 26, Núm. 2, pp. 354-363

2019

  1. Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: Cohort A of the phase II KEYNOTE-086 study

    Annals of Oncology, Vol. 30, Núm. 3, pp. 397-404

2015

  1. A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

    British Journal of Cancer, Vol. 112, Núm. 4, pp. 650-659

2014

  1. A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial

    Breast, Vol. 23, Núm. 5, pp. 656-662

2012

  1. Safety of bevacizumab in metastatic breast cancer patients undergoing surgery

    European Journal of Cancer, Vol. 48, Núm. 4, pp. 475-481